Synthesis and biological evaluation of 2,5-di(7-indolyl)-1,3,4-oxadiazoles, and 2- and 7-indolyl 2-(1,3,4-thiadiazolyl)ketones as antimicrobials. 2014

Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
School of Chemistry, The University of New South Wales, Sydney, NSW 2052, Australia; School of Chemistry, Faculty of Art and Science, Namık Kemal University, Turkey.

A range of novel hydrazine bridged bis-indoles was prepared from readily available indole-7-glyoxyloylchlorides and 7-trichloroacetylindoles and underwent cyclodehydration to produce 2,5-di(7-indolyl)-1,3,4-oxadiazoles and a 2,2'-bi-1,3,4-oxadiazolyl with phosphoryl chloride in ethyl acetate. This efficient protocol was subsequently used for the synthesis of 2- and 7-indolyl 2-(1,3,4-thiadiazolyl)ketones from related indolyl-hydrazine carbothioamides. The synthesised bis-indoles were evaluated for their antimicrobial properties, particularly the inhibition of protein-protein complex formation between RNA polymerase and σ factor and their bactericidal effect on Gram positive Bacillus subtilis and Gram negative Escherichia coli.

UI MeSH Term Description Entries
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012321 DNA-Directed RNA Polymerases Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992). DNA-Dependent RNA Polymerases,RNA Polymerases,Transcriptases,DNA-Directed RNA Polymerase,RNA Polymerase,Transcriptase,DNA Dependent RNA Polymerases,DNA Directed RNA Polymerase,DNA Directed RNA Polymerases,Polymerase, DNA-Directed RNA,Polymerase, RNA,Polymerases, DNA-Dependent RNA,Polymerases, DNA-Directed RNA,Polymerases, RNA,RNA Polymerase, DNA-Directed,RNA Polymerases, DNA-Dependent,RNA Polymerases, DNA-Directed
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
September 2013, ChemMedChem,
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
May 2013, European journal of medicinal chemistry,
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
December 1993, Die Pharmazie,
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
August 2009, Bioorganic & medicinal chemistry letters,
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
March 2014, Molecules (Basel, Switzerland),
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
April 2011, European journal of medicinal chemistry,
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
November 2012, ChemMedChem,
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
November 2022, Molecules (Basel, Switzerland),
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
April 2013, European journal of medicinal chemistry,
Hakan Kandemir, and Cong Ma, and Samuel K Kutty, and David Stc Black, and Renate Griffith, and Peter J Lewis, and Naresh Kumar
May 1982, Die Pharmazie,
Copied contents to your clipboard!